Controllable self-annealing microgel particles for biomedical applications
A microporous gel system for certain applications, including biomedical applications, includes an aqueous solution containing plurality of microgel particles including a biodegradable crosslinker. In some aspects, the microgel particles act as gel building blocks that anneal to one another to form a covalently-stabilized scaffold of microgel particles having interstitial spaces therein. In certain aspects, annealing of the microgel particles occurs after exposure to an annealing agent that is endogenously present or exogenously added. In some embodiments, annealing of the microgel particles requires the presence of an initiator such as exposure to light. In particular embodiments, the chemical and physical properties of the gel building blocks can be controlled to allow downstream control of the resulting assembled scaffold. In one or more embodiments, cells are able to quickly infiltrate the interstitial spaces of the assembled scaffold.
1. A method of delivering to living mammalian tissue a covalently-stabilized porous scaffold of spherical microgel particles comprising:
(a) delivering to the living mammalian tissue a plurality of flowable, spherical microgel particles comprising diameters between 10 micrometers to 1000 micrometers, the plurality of flowable, spherical microgel particles comprising a cross-linked poly(ethylene glycol) (PEG) backbone polymer cross-linked with a matrix metalloprotease (MMP)-degradable crosslinker and an annealing component comprising K-peptides and Q-peptides and a cell-adhesive peptide comprising RGD; and
(b) following delivery in (a) exposing the flowable, spherical microgel particles to an annealing agent comprising Factor XIIIa that links the flowable, spherical microgel particles together via a covalent annealing reaction at points of physical contact between adjacent spherical microgel particles via the K peptides and Q-peptides to form the covalently-stabilized porous scaffold, wherein the covalently-stabilized porous scaffold comprises pores with a median diameter of about 10 to about 35 micrometers into which cells from the living mammalian tissue become integrated within forty-eight hours of exposing in (b).